L3042

Levocabastine hydrochloride

≥99% (HPLC), solid

• 동의어(들): Levophta, Levostin, R50547, [3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid
• 실험식(Hill 표기법): C₂₆H₂₉N₂O₂F·HCl
• CAS Number: 79547-78-7
• Molecular Weight: 456.98
• MDL number: MFCD07787408
• UNSPSC 코드: 12352200
• PubChem Substance ID: 329817402

속성

• 분석: ≥99% (HPLC)
• 형태: solid
• 색상: white
• solubility: DMSO: soluble ~10 mg/mL
• 주관자: Johnson & Johnson
• SMILES string: Cl[H].C[C@@H]1CN(CC[C@]1(C(O)=O)c2ccccc2)[C@@H]3CC[C@@](CC3)(C#N)c4ccc(F)cc4
• InChI: 1S/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m1./s1
• InChI key: OICFWWJHIMKBCD-VALQNVSPSA-N
• 유전자 정보: human ... HRH1(3269)

설명

생화학적/생리학적 작용

Non-peptide histamine H₁ receptor antagonist; neurotensin NTS₂ receptor ligand.

특징 및 장점

This compound is featured on the Neurotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H315,H319,H335
• 예방조치 성명서: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 표적 기관: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• 개인 보호 장비: dust mask type N95 (US), Eyeshields, Gloves